Patent · US Active

Antibodies to NTB-A

US8993726B2 · kind B2 · utility

0Cited by

3References

12Claims

0Family size

Assignees

Nuvelo, Inc. · US
ARCA Biopharma, Inc. · US

Inventors

Arie Abo · Oakland, US
Wouter Korver · South San Francisco, US

Key dates

Filing date	Jun 4, 2012
Grant date	Mar 31, 2015
Priority date	—
Expiry date	Jun 4, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-NTB-A antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind NTB-A and treat diseases, such as hematologic malignancies, which are characterized by expression of NIB-A.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.